Total Payments
$1,837
2024 Payments
$134.64
Companies
17
Transactions
40
Medicare Patients
287
Medicare Billing
$27,993
Payment Breakdown by Category
Food & Beverage$1,710 (93.1%)
Education$127.30 (6.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,710 | 38 | 93.1% |
| Education | $127.30 | 2 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $579.87 | 8 | $0 (2024) |
| Genentech USA, Inc. | $261.56 | 4 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $230.93 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 1 | $0 (2022) |
| ABBVIE INC. | $122.00 | 7 | $0 (2024) |
| Lundbeck LLC | $98.83 | 1 | $0 (2017) |
| PORTOLA PHARMACEUTICALS, INC. | $83.33 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $74.85 | 5 | $0 (2022) |
| Adamas Pharmaceuticals, Inc. | $74.04 | 1 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $47.62 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.64 | 4 | Biogen, Inc. ($85.63) |
| 2023 | $140.32 | 3 | Biogen, Inc. ($116.23) |
| 2022 | $327.42 | 6 | Biogen, Inc. ($172.26) |
| 2021 | $383.34 | 9 | Biogen, Inc. ($205.75) |
| 2020 | $46.51 | 3 | Novartis Pharmaceuticals Corporation ($27.33) |
| 2019 | $131.32 | 2 | Alexion Pharmaceuticals, Inc. ($108.33) |
| 2018 | $416.78 | 9 | Alexion Pharmaceuticals, Inc. ($122.60) |
| 2017 | $256.58 | 4 | Genentech USA, Inc. ($122.12) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Immunology | ||||||
| 06/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $85.63 | General |
| Category: Neurology | ||||||
| 05/04/2023 | Biogen, Inc. | TECFIDERA (Drug) | Education | In-kind items and services | $67.30 | General |
| Category: Neurology | ||||||
| 05/02/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $48.93 | General |
| Category: Neurology | ||||||
| 01/04/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2022 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $77.41 | General |
| Category: Neurology | ||||||
| 12/07/2022 | Biogen, Inc. | TYSABRI (Biological), PLEGRIDY, VUMERITY | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: Neurology | ||||||
| 11/08/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neuroscience | ||||||
| 04/27/2022 | Biogen, Inc. | TYSABRI (Biological) | Education | In-kind items and services | $60.00 | General |
| Category: Neurology | ||||||
| 03/24/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2021 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | Cash or cash equivalent | $80.75 | General |
| Category: NEUROLOGY | ||||||
| 11/02/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2021 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $74.96 | General |
| Category: Immunology | ||||||
| 06/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2021 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: NEUROLOGY | ||||||
| 03/24/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: PRIMARY CARE | ||||||
| 12/16/2020 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2020 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: ADENOSINE A2A RECEPTORS | ||||||
| 11/18/2020 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 58 | 87 | $7,748 | $3,693 |
| 2022 | 4 | 85 | 117 | $20,051 | $7,842 |
| 2021 | 3 | 61 | 80 | $7,052 | $4,648 |
| 2020 | 5 | 83 | 117 | $31,709 | $11,811 |
Total Patients
287
Total Services
401
Medicare Billing
$27,993
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 31 | 49 | $3,690 | $2,272 | 61.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 13 | $1,553 | $783.50 | 50.5% |
| 62369 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump | Facility | 2023 | 15 | 25 | $2,505 | $637.50 | 25.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $8,496 | $2,524 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 35 | $3,681 | $2,124 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 27 | 46 | $3,482 | $1,812 | 52.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 18 | $4,392 | $1,383 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 26 | 40 | $2,912 | $2,005 | 68.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 29 | $2,776 | $1,750 | 63.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $1,364 | $892.80 | 65.5% |
| J0475 | Injection, baclofen, 10 mg | Office | 2020 | 12 | 37 | $10,693 | $5,032 | 47.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 29 | 29 | $9,599 | $3,068 | 32.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 20 | $5,000 | $1,563 | 31.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 14 | $2,898 | $1,157 | 39.9% |
| 95990 | Refilling and maintenance of implantable spinal or brain drug delivery pump or reservoir | Office | 2020 | 12 | 17 | $3,519 | $991.20 | 28.2% |
About Dr. Calvin Hansen, MD
Dr. Calvin Hansen, MD is a Neurology healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639157373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Calvin Hansen, MD has received a total of $1,837 in payments from pharmaceutical and medical device companies, with $134.64 received in 2024. These payments were reported across 40 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,710).
As a Medicare-enrolled provider, Hansen has provided services to 287 Medicare beneficiaries, totaling 401 services with total Medicare billing of $27,993. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Des Moines, IA
- Active Since 01/04/2006
- Last Updated 02/27/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1639157373
Products in Payments
- VUMERITY (Drug) $288.04
- SOLIRIS (Drug) $230.93
- TYSABRI (Biological) $224.53
- Activase (Biological) $141.89
- ZEPOSIA (Drug) $125.00
- ONFI (Drug) $98.83
- UBRELVY (Drug) $88.74
- ANDEXXA (Drug) $83.33
- OCREVUS (Biological) $74.96
- GOCOVRI (Drug) $74.04
- TECFIDERA (Drug) $67.30
- KESIMPTA (Drug) $47.52
- QULIPTA (Drug) $33.26
- MAYZENT (Drug) $27.33
- Aimovig (Biological) $26.05
- Cardiac Monitoring Suite (Device) $22.99
- Radicava (Drug) $21.57
- AUSTEDO (Drug) $19.22
- NOURIANZ (Drug) $19.18
- BRIUMVI (Drug) $18.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Des Moines
Bruce Hughes, Md, MD
Neurology — Payments: $2.3M
Neurology $2.3M
Michael Jacoby, Md, MD
Neurology — Payments: $247,801
Neurology $247,801
Lynn Rankin, Md, MD
Neurology — Payments: $222,800
Neurology $222,800
Paul Babikian, Md, MD
Neurology — Payments: $162,701
Neurology $162,701
Wendy Zadeh, Md, MD
Neurology — Payments: $138,438
Neurology $138,438
Mark Puricelli, Do, DO
Neurology — Payments: $70,851
Neurology $70,851